is a Professor and Director of the Center for viral onco at the University of Kansas Medical Center. Expert in the fields of human leukemia & tumor virology. Research includes telomere-telomerase biology, dysfunction of specific signaling pathways in cancer cells, in particular, the Jak/STAT & Notch pathways.
is a CEO, Middle-East Association for Cancer Research, Canada, USA. His main research focuses on the roles of several Oncogenes and Oncoviruses’s, especially high-risk HPV, in human carcinogenesis and metastasis as well as the roles of EGF-receptor members and their interactions with cell-cell adhesion proteins in the progression of human cancer.
is a Director of R&D (Translational Oncology) at ScyTek Labs, USA. His research interests include molecular oncology, discoveries on predictive cancer markers and explored the prospects of newer intra-lesional adjuvant immunotherapeutic in Human melanoma. He is a noted expert in melanoma stem cell research.
is an Associate Director of Research, Interim Co-Chief & Director of Translational Medicine Laboratory, Division of Hematology-Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, USA. His research interests focus on Anti-cancer Drug Development, Theragnostic Drug and Biomarker Discovery and Development, Translational Research, Hematology Oncology.
is a Professor & Head of the Division of Biostatistics, Department of Public Health & Preventive Medicine, Walter &Clora Brownfield Endowed Professor of Cancer Biostatistics, USA. Research interest includes clinical trial designs for molecularly targeted agents, biomarker validation & evaluation of personalized medicine in treatment & prevention settings.
is a Professor of Experimental Pathology at the University of Southampton, UK. He leads a group that investigates the mechanisms regulating tumor cell invasion and the role of the microenvironment in promoting tumor progression, identifying potential prognostic biomarkers and therapeutic targets, including the molecular characterisation of cancer-associated fibroblasts.
is the President of the WAMS, the World Academy of Medical Sciences, Enschede, Netherlands. He is an eminent research scientist in Molecular Oncology. His main research interests include Cancer Stem Cells, Tumor Cell Biology, Oncogenesis, Molecular Oncopathology, Cell Signaling, Signal Transduction and Extracellular Matrix.
is R&D Director and Heading Formulation R&D, Analytical R&D & Regulatory affairs department, Yiling International, Beijing, China. He is Currently doing research on Anti-cancer, Hormones & Other Generic solid dosage forms.
is a Professor of Anatomic pathology at School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia. Her research interests are in gynae pathology particularly cervical cancer and on thyroid lesions. She underwent several pathology subspecialty training from University of Western Australia, University of Sydney, University of Toronto and University of Cape Town.
is a Professor of Medicine at the University of California, Los Angeles & at the NUS, Senior Principal Investigator at the Cancer Science Institute of Singapore, & Deputy Director of Research at the National University Cancer Institute of Singapore. They study the molecular and cellular biology of cancer and translate these findings into an improvement of health care for patients with cancer.
is a Professor of Human Genetics and Development at UQUDENT, Saudi Arabia. He is the member of Genetics Society of America, Japanese Society for Molecular Biology, American Society of Cell Biology. His research interest includes oncology, nanotechnology, toxicology, pharmacology, public health, human genetics, development, cell biology and neurosciences.
is a Professor in the Associate Vice President of Global Medical Development & Associate Dean of International Research, College of Pharmacy, University of South Florida, Tampa (USF), Florida. His major research interests are systems pharmacology, drug metabolism & drug transport,pharmacokinetics or pharmacometrics, pharmacogenomics, nanomedicine and Chinese medicine.
is a Professor of Medical Science, Perelman School of Medicine, University of Pennsylvania, Philadelphia. His laboratory is interested in early detection of tumors, having reported a powerful new technology, combining simple immunologic recognition with a T7 polymerase-mediated amplification mechanism, allowing for subfemtomolar detection of neu in serum.
is a Professor in Department of Cancer Sciences, University of Glasgow and Beatson Institute for Cancer Research, USA. They investigate the impact of chromatin structure & epigenetics on cell proliferation, aging and cancer and they hypothesize that age-associated changes in chromatin structure, function & regulation contribute to the dramatic age-associated increase in incidence of cancer.
is a Professor of Cancer Cell Biology, National Health and Medical Research Council Senior Principal Research Fellow in the Department of Pathology and Bosch Institute, University of Sydney. His research focuses on understanding the role of iron in cancer cell proliferation and the development of novel anti-tumor agents known as iron chelators.
is a Professor of Pathology, Xinxiang Medical University, China, and a Professor of Medicine, Jinan University (Guangzhou), China, and an Associate Professor of Pathology, University of Illinois at Chicago, USA. His main research interests include gastrointestinal carcinogenesis, metastasis and prevention, cell signaling and signal transduction.
is a professor, School of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong.His research focuses on ion channels, especially Ca2+-permeable channel in cardiovascular systems, cancer cells and cardiac stem cells. He had been one of the leading scientists in the fields of Ca2+ signaling in cardiovascular system.
is a Professor of Biochemistry at Huazhong Agricultural University, China. Her research interest lies in two aspects, one on protein-nucleic acid interactions and their roles in diseases including cancer, the other relating to antibiotic resistance.
is a Professor of molecular biology at Gembloux Agro Bio-Tech, Belgium. His research interest focuses on role, mechanisms and therapeutic potential of epigenetic regulation in cancer. His field of interest is on Molecular and cellular biology of retroviruses, Epigenetics in treatment of chronic lymphocytic leukemia, mesothelioma and lung cancer.
is a Research Assistant Professor College of Medicine, University of Illinois at Chicago. His research focuses on developing novel molecular targeted drugs for cancer and sickle cell disease by epigenetic molecular switch on and off in order to enhance quantity as well as quality of human life.
is an Associate Professor of surgery, the Edward G. Schlieder Chair in Surgical Oncology and the Chief of Endocrine Surgery sections at Tulane University Medical School, New Orleans, LA. His research focuses on clinical outcome research related to endocrine surgery patients, anti-tumor efficacies of multiple pathways targeting in advanced thyroid cancer.
is an Associate Professor at Department of Therapeutic Radiology of Yale University, an ABR board certified medical physicist at Yale-New Haven Hospital, USA. His research has been focused on medical imaging and its applications in cancer radiotherapy.
is an Associate Professor & Vice Chair for Research in the Department of Structural & Cellular Biology at Tulane University,USA. His research interest is in inflammation & cancer, focusing on how interleukin-17 promotes initiation & progression of prostate,lung & other cancers, demonstrates immune cells & their products play important roles in cultivation of the tumor microenvironment.
is an Associate Professor of Clinical Medicine at Montefiore Medical Center, Bronx, N.Y, USA. She is a rotating member of the Esophago Gastric Task Force of the National Cancer Institute Gastrointestinal Cancer Steering Committee. She is developing new therapies for gastrointestinal malignancies.
is an Associate Professor at Tulane University, USA. Research interests are to understand the mechanisms involved in resistance of prostate cancer to hormone therapy, they are characterizing the mechanisms by which androgen receptor splice variants mediate therapy resistance & developing agents to target these androgen receptor splice variants for prostate cancer therapy.
is an Associate Professor at University of Illinois in the Department of College of dentistry, USA. His research interest is to utilize high-throughput genomics and bioinformatics technologies to gain a better understanding of this disease process and to develop novel diagnostic tools for head and neck/oral squamous cell carcinoma (SCC) patients.
is an Associate Professor in the School of Biomedical Sciences at the Chinese University of Hong Kong. His research focuses on the transcriptional and epigenetic mechanisms of gastrointestinal carcinogenesis.
is an Associate Professor of radiation oncology; cell, developmental, and integrative biology; pharmacology & toxicology at the University of Alabama at Birmingham, USA. Research on targeting DNA repair pathways as part of therapeutic strategies against cancer. Has a strong interest in molecular profiling of cancer-related pathways using the Nanostring nCounter platform.
is a Medical Oncologist and Clinical Assistant Professor of Medicine at the University of Iowa Carver College of Medicine, USA. His research interests are in the field of breast cancer, in particular in high risk patients and development of new therapies.
is working as a specialist urologist at Tepecik Educational and Research Hospital, Urology Department, Izmir, Turkey. His research interests include in surgical treatment (laparoscopy/robotic techniques) of kidney ,bladder and prostate cancer also my research interest includes molecular and genetic pattern of early stage kidney cancer and evaluation of organ-sparing surgery.
is a internist/medical oncologist at his own practice in Athens, Greece. He is currently working on tumour markers (predictive & prognostic) as well as exploration of cancer signalling pathways for the development of new targeted agents.
is an Assistant Professor in Colorectal Oncology and Geriatrics at Memorial Sloan Kettering Cancer Center, NY, USA. Research is focuses on treatment of older patients with cancer especially colorectal cancer, in improving quality of care, symptom management, and utilizing novel communication and monitoring technologies to avoid hospitalization and emergency department.
is an Assistant Professor of Pathology & Laboratory Medicine at the University of Kansas Medical Center, USA. Her research interests include leukemia, lymphoma, and flow cytometry immunophenotyping of these hematopoietic neoplasms, particularly flow cytometric detection of minimal residual disease of acute myeloid leukemia.
is an Assistant Professor at Mitchell Cancer Institute, Drug Discovery Research Center, USA. With a long-term experience in tumorigenesis, chemoprevention and cancer biology, his research expertise is cyclic nucleotide signaling and phosphodiesterase that control tumor proliferation and apoptosis. His current studies are focusing on PDE10 and lung cancer.
is a Research Assistant Professor at the University Of Illinois College Of Medicine at Peoria, USA. His research interests include Mechanisms of cancer cell invasion, migration, MAPK signaling, Apoptosis and cancer stemness in pancreatic and Central Nervous system tumors.
is an Assistant Professor at University of Illinois at Chicago, College of Medicine, USA. Research on hypoxia signaling in lung diseases, evidence suggests that the epithelial-mesenchymal transition participates in the tumor invasion & metastasis they investigate whether hypoxic environment contributes to tumor metastasis via promoting tumor cell EMT.
is a Research Assistant Professor in the Department of Biochemistry and Molecular Biology and the Tulane Cancer Center at Tulane University School of Medicine, USA. Her research interest is targeting the p53-pathway for the treatment of cancer, study of p53 regulators by a combination of biochemical and structural analyses, and small molecule drug discovery and development.
is an Assistant Professor at Children’s hospital of Pittsburgh, USA. His research interests include all pancreas-related diseases (such as Diabetes, pancreatitis, and pancreatic cancer) and the biology of stem/progenitor cells/cancer stem cells. He has now publications as first or corresponding author at PNAS, JCI, Diabetes, Diabetologia and JBC, etc.
is an Assistant Professor of Radiology at Mayo Clinic Rochester MN, USA. Where, his research focused on development of PET imaging probe for diagnosis of hypoxic cancer and neurodegenerative diseases.
is an Assistant Professor of Pediatrics at Harbor-UCLA and LA BioMed, USA. Her research focused on studying the mechanism of phosphoramidate hydrolases to enable rational design of anti-viral and anti-cancer prodrugs. She is now employing quantitative proteomic approaches to identify biomarkers and substrates of p97 to enable evaluation of p97 as a potential anti-cancer target.
is an Assistant Professor of the School of Biomedical Sciences, The Chinese University of Hong Kong. His research focuses in skeletal biology, pathogenesis and progression of skeletal related diseases and cancers, and regulation of signaling pathways in cell lineage differentiation and metastasis.
is the Head of Molecular Research and Services laboratory, INFO valley Life Sciences Sdn Bhd. Her research interests includes Familial Hypercholesterolemia, Cancers & SNPs/mutations associated with it, Risk scoring algorithms, Yeast genetics, Cloning & expression of therapeutic proteins &Forensic science, Digital autopsy & human identification using molecular methods.
is working as a faculty at Department of Genetics, Cell Biology & Anatomy, College of Medicine, University of Nebraska Medical Center. His research interests include analysis of genomic data, systems and computational biology approach to cancer classification and prediction, cancer genomic evolution, identification of synthetic lethal genes for cancer therapy.
is a Senior Researcher in Clinical Research Centre, The Second Clinical Medical College of Jinan University, Shenzhen, China. His research interest focuses on focused on cell therapy. His specific experimental techniques include Molecular cloning techniques, protein-protein interaction analysis: Co-IP, FRET, phage-displayed peptide library screening & identification, tumor angiogenesis, etc.
is a Cancer Nanotechnology Scientist and working as a Research Faculty in Department of Experimental Radiation Oncology at The University of Texas MD Anderson Cancer Center, Houston, USA. His research interests includes research areas such as cancer nanotechnology, pharmaceutical, environmental and bio-medical fields using diverse state-of-the-art techniques.
is an Associate Scientist at Medicine/Cancer Center,Albert Einstein College of Medicine, USA. His research interests include but not limited to deciphering the Xenobiotic receptor’s role in pathophysiological condition & cancer.
is working as a Scientist Seaside Therapeutics, LLC. Cambridge MA, United States. His research interest includes pathophysiology of cancer and immune-related diseases, functions of enzymes in the pathogenesis of cancer and immune-related diseases, novel therapeutics for cancer and immune-related diseases, such as small molecules and stem cells.
is a member of American Cancer Society fellow at the Medical University of South Carolina’s Hollings Cancer Center in the Department of Cell and Molecular Pharmacology and Experimental Therapeutics, USA. His research interests focus on molecular mechanisms that regulate epithelial cell organization & cell polarity as it relates to the tumor microenvironment, cell migration/invasion.
currently holds Vice Chancellor Fellow position in Institute of Health and Biomedical Innovation, China. He is a high-profile young scientist with over 8 years’ research and management experiences in the fields of metabolomics, chemical biology, pharmaceutical sciences and Traditional Chinese Medicine. He has received two national competitive research grants and 5 research fellowships.
is currently working in the Department of pathology at University of Sydney, Australia. Her research career has been dedicated to the design and development of novel iron chelators as potent cancer chemotherapeutic agents. Her research focused on the pharmacodynamics & cellular uptake of novel 14C-labelled iron chelators and the ability of human serum albumin to affect these factors.
is a Postdoctoral Research Fellow in Chemistry, California South University, Irvine, California, USA. His research interests are Biophysical Chemistry, Nanochemistry, Quantum Chemistry, Biomolecular and Vibrational Spectroscopy, Molecular Modeling and Structure, Theoretical, Computational and Mathematical Chemistry, Ab initio and Density Functional Methods.
is working as a Researcher at SSR Medical College, Belle Rive, Mauritius. He is a physician with over a dozen research publications in reputed Medical Journals. He had also authored four medical books His research interest includes Oxidative Stress, Development of new Surgical Procedures.